Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Myelin-oligodendrocyte glycoprotein antibody-associated disease

R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment

JL Bennett, F Costello, JJ Chen, A Petzold… - The Lancet …, 2023 - thelancet.com
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune
neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein …

A review of cytokine-based pathophysiology of Long COVID symptoms

RN Low, RJ Low, A Akrami - Frontiers in medicine, 2023 - frontiersin.org
The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

R Höftberger, Y Guo, EP Flanagan… - Acta …, 2020 - Springer
We sought to define the pathological features of myelin oligodendrocyte glycoprotein (MOG)
antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We …

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - neurology.org
Objective Myelin oligodendrocyte glycoprotein–immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …

Optic neuritis

JL Bennett - Continuum: lifelong learning in neurology, 2019 - journals.lww.com
PURPOSE OF REVIEW This article discusses the clinical presentation, evaluation, and
management of the patient with optic neuritis. Initial emphasis is placed on clinical history …

Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids

Y Matsumoto, K Kaneko, T Takahashi, Y Takai… - Brain, 2023 - academic.oup.com
The spectrum of MOG-IgG-associated disease (MOGAD) includes optic neuritis (ON),
myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis …

[HTML][HTML] EU paediatric MOG consortium consensus: Part 1–Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated …

AL Bruijstens, C Lechner, L Flet-Berliac, K Deiva… - European Journal of …, 2020 - Elsevier
Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …